Preoperative Attention/Memory Problem Affects the Quality of Life of Parkinson’s Disease Patients after Deep Brain Stimulation: A Cohort Study

Table 1

Demographic and disease information (N = 93).

Variable	Group	/number (%)
Age	—	62.94 ± 9.68
Disease duration (year)	—	9.61 ± 4.31
LEDD (mg/day)	—	553.76 ± 307.72
UPDRS-III	—	59.24 ± 11.82
Gender	Male	55 (59.1)
	Female	38 (40.9)
H–Y stage	2.0	11 (11.8)
	2.5	23 (24.8)
	3.0	43 (46.2)
	4.0	16 (17.2)

LEDD: levodopa equivalent daily doses and H–Y stage: Hoehn–Yahr stage.